Yodo Salil Ointment
NDC Package 87845-101-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Yodo Salil (ointment) ointment is wet affected area• Apply product and massage gently• Rinse thoroughly• Use one to three times daily• Because excessive drying of the skin may occur, start withone application daily, then gradually increase if needed• If bothersome dryness or peeling occurs, reduceapplication to once a day or every other day. This formulation utilizes a ointment delivery system. Marketed by Laboratorio Neo Farmaco Del Ecuador Neofarmaco Cia. Ltda., this product is identified by NDC 87845-101 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
87845-101-01
Package Description
120 g in 1 PACKAGE
Product Code
87845-101
11-Digit Billing Format
87845010101

Clinical Specifications

Proprietary Name
Yodo Salil
Non-Proprietary Name
Ointment
Substance Name
Povidone-iodine; Camphor, (-)-; Methyl Salicylate
Dosage Form
Ointment - A semisolid3 dosage form, usually containing <20% water and volatiles5 and >50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
Wet affected area• Apply product and massage gently• Rinse thoroughly• Use one to three times daily• Because excessive drying of the skin may occur, start withone application daily, then gradually increase if needed• If bothersome dryness or peeling occurs, reduceapplication to once a day or every other day

Regulatory & Marketing

Labeler Name
Laboratorio Neo Farmaco Del Ecuador Neofarmaco Cia. Ltda.
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-01-2026
End Marketing Date
12-01-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 87845-101-01 identifies a specific commercial package of 120 g in 1 package of Yodo Salil, a human over the counter drug labeled by Laboratorio Neo Farmaco Del Ecuador Neofarmaco Cia. Ltda.. This ointment is formulated for topical use and contains povidone-iodine; camphor, (-)-; methyl salicylate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Laboratorio Neo Farmaco Del Ecuador Neofarmaco Cia. Ltda. on January 01, 2026.

How is this Laboratorio Neo Farmaco Del Ecuador Neofarmaco Cia. Ltda. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 87845010101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
87845-101-01
11-Digit CMS (5-4-2)
87845-0101-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.